Serum gets DCGI nod for Phase 2 & 3 trials

Serum gets DCGI nod for Phase 2 & 3 trials
https://ift.tt/2Xp9JnX India’s apex drug regulator has allowed Pune-based Serum Institute of India to conduct late-stage — Phase 2 and 3 — human trials in India for the Oxford University Covid-19 vaccine candidate.

https://ift.tt/eA8V8J from Times of India https://ift.tt/2Xp9JnX

via Blogger https://ift.tt/3grUmCU
August 04, 2020 at 08:32AM